Bibliography (27):

  1. DNAm PhenoAge: An epigenetic biomarker of aging for lifespan and healthspan

  2. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease

  3. Senolytic vaccination improves normal and pathological age-related phenotypes and increases lifespan in progeroid mice

  4. TRIIM: Reversal of epigenetic aging and immunosenescent trends in humans

  5. Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test